Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets (Unaudited)

v3.23.2
Condensed Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 235,095 $ 47,254
Marketable securities 123,198 255,090
Investment in equity securities 33,349 32,020
Accounts receivable 9,999 7,122
Prepaid expenses and other current assets 10,344 11,667
Total current assets 411,985 353,153
Property and equipment, net 23,636 24,621
Operating lease right-of-use assets 25,138 26,443
Other non-current assets 3,268 1,855
Restricted cash 872 872
Total assets 464,899 406,944
Current liabilities:    
Accounts payable 3,856 4,797
Accrued compensation 9,509 13,142
Deferred revenue—current 18,036 16,759
Operating lease liability - current 5,934 4,585
Debt—current 10,197 12,500
Accrued expenses and other current liabilities 19,593 14,764
Total current liabilities 67,125 66,547
Deferred revenue - non-current 79,880 89,885
Operating lease liability - non-current 26,526 29,574
Debt—non-current   3,771
Deferred royalty obligation related to the sale of future royalties 136,653  
Other non-current liabilities   119
Total liabilities 310,184 189,896
Commitments and contingencies (Note 7)
Stockholders’ equity:    
Preferred stock, $0.001 par value - 10,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 0 shares issued and outstanding as of June 30, 2023 and December 31, 2022
Common stock, $0.001 par value - 300,000,000 shares authorized as of June 30, 2023 and December 31, 2022; 60,471,041 and 57,499,541 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively 60 58
Additional paid-in-capital 695,828 670,223
Accumulated other comprehensive loss 16 (618)
Accumulated deficit (541,189) (452,615)
Total stockholders’ equity 154,715 217,048
Total Liabilities and Stockholders’ Equity $ 464,899 $ 406,944